Dr. Reddy's Laboratories Ltd. expands further into consumer health with a £500m ($632m) agreement to acquire rights to OTC nicotine replacement therapy products Haleon plc markets outside the US.
The Indian pharma giant gains rights to a global portfolio of OTC NRT brands marketed outside the US. The acquisition...








